close
close

Routine tests may reduce disparities in peripheral artery disease and amputation risk

Routine tests may reduce disparities in peripheral artery disease and amputation risk

Standard testing that is inexpensive may help reduce disparities in care and lower the amputation risk for people with peripheral artery disease, according to a new science report.

The report, published Thursday as an American Heart Association scientific statement, summarizes racial and ethnic disparities in treatment of the disease and suggests ways to improve care. The statement appeared in the journal Circulation.

Peripheral artery disease, or PAD, is caused by fatty plaque buildup in the arteries that carry blood to the extremities. PAD causes cramping, pain or weakness in leg and foot muscles when a person walks. An estimated 7 million to 12 million people in the U.S. – and 200 million people worldwide – have PAD. They’re at increased risk for limb amputation and death from cardiovascular disease. Those with PAD and Type 2 diabetes have a higher rate of complications.

“This debilitating condition has devastating outcomes … which often leads to lower quality of life and increased disability,” Dr. Carlos Mena-Hurtado, chair of the statement writing group, said in a news release.

  • June 15, 2023